Patterning of brain organoids derived from human pluripotent stem cells.


Journal

Current opinion in neurobiology
ISSN: 1873-6882
Titre abrégé: Curr Opin Neurobiol
Pays: England
ID NLM: 9111376

Informations de publication

Date de publication:
06 2022
Historique:
received: 08 11 2021
revised: 27 02 2022
accepted: 03 03 2022
pubmed: 12 4 2022
medline: 7 6 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

The emerging technology of brain organoids deriving from human pluripotent stem cells provides unprecedented opportunities to study human brain development and associated disorders. Various brain organoid protocols have been developed that can recapitulate some key features of cell type diversity, cytoarchitectural organization, developmental processes, functions, and pathologies of the developing human brain. In this review, we focus on patterning of human stem cell-derived brain organoids. We start with an overview of general procedures to generate brain organoids. We then highlight some recently developed brain organoid protocols and chemical cues involved in modeling development of specific human brain regions, subregions, and multiple regions together. We also discuss limitations and potential future improvements of human brain organoid technology.

Identifiants

pubmed: 35405627
pii: S0959-4388(22)00030-7
doi: 10.1016/j.conb.2022.102536
pmc: PMC9167774
mid: NIHMS1797217
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102536

Subventions

Organisme : NINDS NIH HHS
ID : R35 NS097370
Pays : United States
Organisme : NIMH NIH HHS
ID : RF1 MH123979
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH125528
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI131130
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS116843
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH105128
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement Nothing declared.

Références

Nat Methods. 2017 Jul;14(7):743-751
pubmed: 28504681
Trends Neurosci. 2021 Feb;44(2):110-121
pubmed: 33203515
Nat Protoc. 2018 Mar;13(3):565-580
pubmed: 29470464
Stem Cell Reports. 2017 May 9;8(5):1144-1154
pubmed: 28416282
Cell Rep. 2015 Feb 3;10(4):537-50
pubmed: 25640179
Development. 2019 Jul 25;146(14):
pubmed: 31239243
Nature. 2021 Oct;598(7881):483-488
pubmed: 34599305
Cell Stem Cell. 2019 Oct 3;25(4):558-569.e7
pubmed: 31474560
Mol Syst Biol. 2018 Jun 26;14(6):e8227
pubmed: 29945941
Nature. 2019 Oct;574(7778):418-422
pubmed: 31619793
Nat Methods. 2015 Jul;12(7):671-8
pubmed: 26005811
Nat Methods. 2019 Jan;16(1):75-78
pubmed: 30573846
Nat Mater. 2021 Feb;20(2):145-155
pubmed: 33199860
Cell Stem Cell. 2017 Aug 3;21(2):274-283.e5
pubmed: 28736217
Nature. 2021 Nov;599(7884):268-272
pubmed: 34707290
Cell Stem Cell. 2017 Sep 7;21(3):349-358.e6
pubmed: 28826723
Nat Biotechnol. 2020 Dec;38(12):1421-1430
pubmed: 33273741
Mol Psychiatry. 2021 Jul;26(7):2964-2976
pubmed: 33051604
Cell Stem Cell. 2020 May 7;26(5):766-781.e9
pubmed: 32142682
Nat Med. 2019 May;25(5):784-791
pubmed: 31061540
Cell Rep. 2022 Jan 25;38(4):110294
pubmed: 35081356
Cell Rep Med. 2020 Mar 25;1(1):100002
pubmed: 33205055
Brain Commun. 2021 Sep 25;3(4):fcab223
pubmed: 34632384
Cell Stem Cell. 2017 Sep 7;21(3):383-398.e7
pubmed: 28757360
Cell Stem Cell. 2020 Sep 3;27(3):361-365
pubmed: 32888425
Nat Neurosci. 2019 Apr;22(4):669-679
pubmed: 30886407
Annu Rev Neurosci. 2022 Jul 8;45:23-39
pubmed: 34985918
Nature. 2018 Apr;556(7702):429-432
pubmed: 29691509
Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002519
pubmed: 20066088
Cell. 2013 May 23;153(5):948-62
pubmed: 23706734
Nat Rev Mater. 2021;6(5):402-420
pubmed: 33623712
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20284-9
pubmed: 24277810
Nat Biotechnol. 2020 Nov;38(11):1265-1273
pubmed: 32451506
Nature. 2013 Sep 19;501(7467):373-9
pubmed: 23995685
Development. 2016 Jun 1;143(11):1884-92
pubmed: 27246712
eNeuro. 2018 Nov 20;5(6):
pubmed: 30460331
Nat Neurosci. 2021 Nov;24(11):1542-1554
pubmed: 34675437
Theranostics. 2019 Jan 1;9(2):311-323
pubmed: 30809276
Nature. 2021 Oct;598(7879):205-213
pubmed: 34616060
Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9
pubmed: 33010822
Nat Methods. 2018 Aug;15(8):631-639
pubmed: 30038414
Cell Rep. 2017 Apr 4;19(1):50-59
pubmed: 28380362
Development. 2018 Jul 30;145(16):
pubmed: 30061169
Nat Rev Neurosci. 2021 Oct;22(10):593-615
pubmed: 34376834
Sci Adv. 2019 Dec 11;5(12):eaax5933
pubmed: 31844664
ACS Synth Biol. 2021 Jun 18;10(6):1465-1480
pubmed: 34019395
Cell Stem Cell. 2021 Sep 2;28(9):1657-1670.e10
pubmed: 33961804
Development. 2019 Apr 16;146(8):
pubmed: 30992274
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6831-E6839
pubmed: 27742791
Nat Rev Neurosci. 2005 Jul;6(7):553-64
pubmed: 15959467
Cell Stem Cell. 2019 Mar 7;24(3):487-497.e7
pubmed: 30799279
Nature. 2017 May 4;545(7652):54-59
pubmed: 28445465
Nat Biotechnol. 2019 Apr;37(4):436-444
pubmed: 30936566
Mol Ther Methods Clin Dev. 2020 Jun 01;18:167-175
pubmed: 32637448
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
Stem Cell Reports. 2019 Sep 10;13(3):458-473
pubmed: 31257131
Dev Biol. 2005 Jun 1;282(1):1-13
pubmed: 15936325
Science. 2014 Jul 18;345(6194):1247125
pubmed: 25035496
NPJ Parkinsons Dis. 2019 Apr 5;5:5
pubmed: 30963107
Cell Stem Cell. 2014 Jul 3;15(1):79-91
pubmed: 24996170
Stem Cell Reports. 2021 Aug 10;16(8):1938-1952
pubmed: 34242615
Nat Med. 2016 Oct;22(10):1101-1107
pubmed: 27571349
RSC Adv. 2018 Jan 5;8(3):1677-1685
pubmed: 35540867
Trends Cell Biol. 2020 Feb;30(2):133-143
pubmed: 31879153
Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5
pubmed: 33113348
Cell. 2017 Nov 2;171(4):877-889.e17
pubmed: 28965759
Nat Biotechnol. 2017 Jul;35(7):659-666
pubmed: 28562594
Annu Rev Neurosci. 2012;35:347-67
pubmed: 22462542
Stem Cells Dev. 2014 Jul 1;23(13):1535-47
pubmed: 24576173
Cell. 2021 Apr 15;184(8):2084-2102.e19
pubmed: 33765444
Cell Stem Cell. 2016 Aug 4;19(2):248-257
pubmed: 27476966
Nat Biotechnol. 2018 Jun;36(5):432-441
pubmed: 29658944
Stem Cell Reports. 2019 Mar 5;12(3):518-531
pubmed: 30799274
Bioact Mater. 2020 Oct 20;6(4):1130-1139
pubmed: 33134606
Nat Rev Neurosci. 2001 Feb;2(2):99-108
pubmed: 11253000

Auteurs

Zhijian Zhang (Z)

Department of Neuroscience and Mahoney Institute for Neurosciences, Philadelphia, PA 19104, USA.

Richard O'Laughlin (R)

Department of Neuroscience and Mahoney Institute for Neurosciences, Philadelphia, PA 19104, USA.

Hongjun Song (H)

Department of Neuroscience and Mahoney Institute for Neurosciences, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, Philadelphia, PA 19104, USA; Institute for Regenerative Medicine, Philadelphia, PA 19104, USA; The Epigenetics Institute, Philadelphia, PA 19104, USA. Electronic address: https://twitter.com/UPenn_SongMing.

Guo-Li Ming (GL)

Department of Neuroscience and Mahoney Institute for Neurosciences, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, Philadelphia, PA 19104, USA; Institute for Regenerative Medicine, Philadelphia, PA 19104, USA; Department of Psychiatry, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: gming@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH